The empagliflozin market is estimated at USD 0.6 billion in 2026, is projected to reach USD 10.4 billion by 2036 and is forecast to register a 33.1% CAGR between 2026 and 2036. In 2026, powder holds 68.4% within the form segment and >=99.5% represents 57.2% of the purity grade category.